Naldemedine: A Review in Opioid-Induced Constipation
Sign Up to like & getrecommendations! Published in 2019 at "Drugs"
DOI: 10.1007/s40265-019-01160-7
Abstract: Naldemedine [Symproic® (Japan; USA); Rizmoic® (EU)], an orally available peripherally acting μ-opioid receptor antagonist (PAMORA), is approved in several countries for the treatment of opioid-induced constipation. In phase III trials, naldemedine was more effective than… read more here.
Keywords: induced constipation; cancer pain; naldemedine; opioid induced ... See more keywords